Condition: Myelodysplastic Syndromes · Sponsor: Takeda
The main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions. Other aims are to learn how well elritercept works in reducing the need for RBC transfusions over longer periods of time or in adults with high transfusion needs. The study will also check on how safe elritercept is and how well it is tolerated.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| Los Angeles Cancer Network | Glendale, California, United States | Recruiting |
| UC San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Smilow Cancer Hospital at Yale-New Haven | New Haven, Connecticut, United States | Recruiting |
| University of Miami Hospital and Clinics | Miami, Florida, United States | Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| ILCC. Illinois Cancer Centers | Peoria, Illinois, United States | Not Yet Recruiting |
| Norton Cancer Institute | Louisville, Kentucky, United States | Recruiting |
| Maryland Oncology Hematolofy | Columbia, Maryland, United States | Recruiting |
| MidAmerica Cancer Care | Kansas City, Missouri, United States | Not Yet Recruiting |
| Comprehensive Cancer Centers of Nevada | Henderson, Nevada, United States | Recruiting |
| Northwell Health | Lake Success, New York, United States | Not Yet Recruiting |
+ 167 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06499285